一、英文文章

 1.             Chen W, Wang JB, Abnet CC, Dawsey SM, Fan JH, Yin LY, Yin J, Taylor PR, Qiao YL, Freedman ND: Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2015, 24(2):386-392. doi: 10.1158/1055-9965.Epi-14-1038.

2.             Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Barnett MJ, Goodman GE, Smith JS, Qiao YL et al: Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study. Cancer Causes Control 2015, 26(12):1835-1844. doi: 10.1007/s10552-015-0676-3.

3.             Huang H, Hu XF, Zhao FH, Garland SM, Bhatla N, Qiao YL: Estimation of Cancer Burden Attributable to Infection in Asia. J Epidemiol 2015, 25(10):626-638. doi: 10.2188/jea.JE20140215.

4.             Jeronimo J, Bansil P, Valdez M, Kang LN, Zhao FH, Qiao YL, Chen W, Zhang X, Paul P, Bai P et al: The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer. J Low Genit Tract Dis 2015, 19(3):220-223. doi: 10.1097/lgt.0000000000000088.

5.             Levin C, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ: An Extended Cost-Effectiveness Analysis of Publicly Financed HPV Vaccination to Prevent Cervical Cancer in China. In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Edited by Gelband H, Jha P, Sankaranarayanan R, Horton S. Washington (DC): The International Bank for Reconstruction and Development / The World Bank © 2015 International Bank for Reconstruction and Development / The World Bank.; 2015. doi: 10.1596/978-1-4648-0349-9_ch18.

6.             Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ: An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine 2015, 33(24):2830-2841. doi: 10.1016/j.vaccine.2015.02.052.

7.             Li J, Kang LN, Li B, Pang Y, Huang R, Qiao YL: Effect of a group educational intervention on rural Chinese women's knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines. BMC Cancer 2015, 15:691. doi: 10.1186/s12885-015-1682-2.

8.             Liao GD, Kang LN, Chen W, Zhang X, Liu XY, Zhao FH, Stoler MH, Mills A, Xi MR, Qiao YL et al: p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer. J Low Genit Tract Dis 2015, 19(3):207-211. doi: 10.1097/lgt.0000000000000080.

9.             Lin CQ, Cui JF, Zhang X, Pan QJ, Chen W, Qiao YL: Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China. Acta Cytol 2015, 59(5):405-411. doi: 10.1159/000441290.

10.          Lin SW, Freedman ND, Shi J, Gail MH, Vogtmann E, Yu G, Klepac-Ceraj V, Paster BJ, Dye BA, Wang GQ et al: Beta-diversity metrics of the upper digestive tract microbiome are associated with body mass index. Obesity (Silver Spring) 2015, 23(4):862-869. doi: 10.1002/oby.21020.

11.           Liu Y, Fan JH, Gao X, Ma L, Qiao YL, Zhang L: The Natural Progression of Parkinson's Disease in a Small Cohort with 15 Drug-na?ve Patients. Chin Med J (Engl) 2015, 128(13):1761-1764. doi: 10.4103/0366-6999.159350.

12.          Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C et al: Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet 2015, 96(3):487-497. doi: 10.1016/j.ajhg.2015.01.011.

13.          Murphy G, Freedman ND, Michel A, Fan JH, Taylor PR, Pawlita M, Qiao YL, Zhang H, Yu K, Abnet CC et al: Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort. Int J Cancer 2015, 137(8):1938-1946. doi: 10.1002/ijc.29543.

14.          Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD et al: Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst 2015, 107(12):djv279. doi: 10.1093/jnci/djv279.

15.          Sankaranarayanan R, Qiao YL, Keita N: The next steps in cervical screening. Womens Health (Lond) 2015, 11(2):201-212. doi: 10.2217/whe.14.70.

16.          Sivasubramaniam PG, Zhang BL, Zhang Q, Smith JS, Zhang B, Tang ZH, Chen GJ, Xie XM, Xu XZ, Yang HJ et al: Breast Cancer Disparities: A Multicenter Comparison of Tumor Diagnosis, Characteristics, and Surgical Treatment in China and the U.S. Oncologist 2015, 20(9):1044-1050. doi: 10.1634/theoncologist.2014-0290.

17.          Song Y, Zhao YQ, Zhang X, Liu XY, Li L, Pan QJ, Shen GH, Zhao FH, Chen F, Chen W et al: Random biopsy in colposcopy-negative quadrant is not effective in women with positive colposcopy in practice. Cancer Epidemiol 2015, 39(2):237-241. doi: 10.1016/j.canep.2015.01.008.

18.          Sung H, Yang HH, Zhang H, Yang Q, Hu N, Tang ZZ, Su H, Wang L, Wang C, Ding T et al: Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers. Int J Epidemiol 2015, 44(4):1341-1352. doi: 10.1093/ije/dyv050.

19.          Trimble EL, Rajaraman PL, Chao A, Gross T, Levin C, Qiao YL, Rebbeck T, Stevens L, Zhao FH: Need for National Commitments to Cancer Research to Guide Public Health Investment and Practice. In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Edited by Gelband H, Jha P, Sankaranarayanan R, Horton S. Washington (DC): The International Bank for Reconstruction and Development / The World Bank © 2015 International Bank for Reconstruction and Development / The World Bank.; 2015. doi: 10.1596/978-1-4648-0349-9_ch15.

20.          Vogtmann E, Flores R, Yu G, Freedman ND, Shi J, Gail MH, Dye BA, Wang GQ, Klepac-Ceraj V, Paster BJ et al: Association between tobacco use and the upper gastrointestinal microbiome among Chinese men. Cancer Causes Control 2015, 26(4):581-588. doi: 10.1007/s10552-015-0535-2.

21.          Wang JB, Dawsey SM, Fan JH, Freedman ND, Tang ZZ, Ding T, Hu N, Wang LM, Wang CY, Su H et al: Common genetic variants related to vitamin D status are not associated with esophageal squamous cell carcinoma risk in China. Cancer Epidemiol 2015, 39(2):157-159. doi: 10.1016/j.canep.2014.12.013.

22.          Wang SM, Hu SY, Chen W, Chen F, Zhao FH, He W, Ma XM, Zhang YQ, Wang J, Sivasubramaniam P et al: Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening. BMC Cancer 2015, 15:848. doi: 10.1186/s12885-015-1882-9.

23.          Wang SM, Qiao YL: Implementation of cervical cancer screening and prevention in China--challenges and reality. Jpn J Clin Oncol 2015, 45(1):7-11. doi: 10.1093/jjco/hyu188.

24.          Wang SM, Yin LY, Zhang Y, Fan JH, Chang IJ, Dawsey SM, Taylor PR, Abnet CC, Qiao YL: Multivitamin and mineral supplementation is associated with the reduction of fracture risk and hospitalization rate in Chinese adult males: a randomized controlled study. J Bone Miner Metab 2015, 33(3):294-302. doi: 10.1007/s00774-014-0589-3.

25.          Wei WQ, Chen ZF, He YT, Feng H, Hou J, Lin DM, Li XQ, Guo CL, Li SS, Wang GQ et al: Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China. J Clin Oncol 2015, 33(17):1951-1957. doi: 10.1200/jco.2014.58.0423.

26.          Wen Y, Pan XF, Huang WZ, Zhao ZM, Wei WQ, Chen F, Lan H, Huang H, Yang CX, Qiao YL: Quality of life for patients with esophageal/gastric cardia precursor lesions or cancer: a one-year prospective study. Asian Pac J Cancer Prev 2015, 16(1):45-51. doi: 10.7314/apjcp.2015.16.1.45.

27.          Yu S, Yang CS, Li J, You W, Chen J, Cao Y, Dong Z, Qiao Y: Cancer Prevention Research in China. Cancer Prev Res (Phila) 2015, 8(8):662-674. doi: 10.1158/1940-6207.Capr-14-0469.

28.          Zhang BL, Sivasubramaniam PG, Zhang Q, Wang J, Zhang B, Gao JD, Tang ZH, Chen GJ, Xie XM, Wang Z et al: Trends in Radical Surgical Treatment Methods for Breast Malignancies in China: A Multicenter 10-Year Retrospective Study. Oncologist 2015, 20(9):1036-1043. doi: 10.1634/theoncologist.2014-0281.

29.          Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, Li M, Ren ZF, Zheng QQ, Ma W et al: Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China. Ann Epidemiol 2015, 25(4):231-235. doi: 10.1016/j.annepidem.2014.12.009.

30.          Zhao J, Zhang X, Chen R, Zhao YQ, Wang TT, He S, Qiao YL: Performance of the R-way Colposcopic Evaluation System in Cervical Cancer Screening. Asian Pac J Cancer Prev 2015, 16(10):4223-4228. doi: 10.7314/apjcp.2015.16.10.4223.

31.          Zhao YQ, Chang IJ, Zhao FH, Hu SY, Smith JS, Zhang X, Li SM, Bai P, Zhang WH, Qiao YL: Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies. BMC Cancer 2015, 15:485. doi: 10.1186/s12885-015-1494-4.

32.          Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, Wang G, Wang XY, Qiao YL: China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thorac Cancer 2015, 6(6):812-818. doi: 10.1111/1759-7714.12287.

33.          Cai H, Ye F, Michel A, Murphy G, Sasazuki S, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH et al: Helicobacter pylori blood biomarker for gastric cancer risk in East Asia. Int J Epidemiol 2016, 45(3):774-781. doi: 10.1093/ije/dyw078.

34.          Chen W, Molijn A, Enqi W, Zhang X, Jenkins D, Yu X, Quint W, Schmidt JE, Li J, Pirog E et al: The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China. Int J Cancer 2016, 139(12):2687-2697. doi: 10.1002/ijc.30401.

35.          Colombara DV, Manhart LE, Carter JJ, Hawes SE, Weiss NS, Hughes JP, Qiao YL, Taylor PR, Smith JS, Galloway DA: Absence of an association of human polyomavirus and papillomavirus infection with lung cancer in China: a nested case-control study. BMC Cancer 2016, 16:342. doi: 10.1186/s12885-016-2381-3.

36.          Fan Y, Jiang Y, Hu P, Chang R, Yao S, Wang B, Li X, Zhou Q, Qiao Y: Modification of association between prior lung disease and lung cancer by inhaled arsenic: A prospective occupational-based cohort study in Yunnan, China. J Expo Sci Environ Epidemiol 2016, 26(5):464-470. doi: 10.1038/jes.2016.22.

37.          Hu N, Kadota M, Liu H, Abnet CC, Su H, Wu H, Freedman ND, Yang HH, Wang C, Yan C et al: Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. Cancer Res 2016, 76(7):1714-1723. doi: 10.1158/0008-5472.Can-15-0338.

38.          Hu N, Wang Z, Song X, Wei L, Kim BS, Freedman ND, Baek J, Burdette L, Chang J, Chung C et al: Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut 2016, 65(10):1611-1618. doi: 10.1136/gutjnl-2015-309340.

39.          Hyland PL, Zhang H, Yang Q, Yang HH, Hu N, Lin SW, Su H, Wang L, Wang C, Ding T et al: Pathway, in silico and tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data. Int J Epidemiol 2016, 45(1):206-220. doi: 10.1093/ije/dyv294.

40.          Katki HA, Zhao FH, Hu SY, Zhang Q, Qiao YL, Schiffman M: Reply to Letter: Using novel risk stratification statistics to better understand the value of screening tests. Int J Cancer 2016, 139(7):1669. doi: 10.1002/ijc.30192.

41.          Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, Hicks B, Dagnall C, Hautman C, Jacobs KB et al: Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. Nat Commun 2016, 7:11843. doi: 10.1038/ncomms11843.

42.          Molijn A, Jenkins D, Chen W, Zhang X, Pirog E, Enqi W, Liu B, Schmidt J, Cui J, Qiao Y et al: The complex relationship between human papillomavirus and cervical adenocarcinoma. Int J Cancer 2016, 138(2):409-416. doi: 10.1002/ijc.29722.

43.          Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, Li Y, Zhen Y, Xu L, Dong G et al: Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study. Thorac Cancer 2016, 7(4):428-436. doi: 10.1111/1759-7714.12350.

44.          Ren J, Murphy G, Fan J, Dawsey SM, Taylor PR, Selhub J, Qiao Y, Abnet CC: Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China. Sci Rep 2016, 6:35281. doi: 10.1038/srep35281.

45.          Valdez M, Jeronimo J, Bansil P, Qiao YL, Zhao FH, Chen W, Zhang X, Kang LN, Paul P, Bai P et al: Effectiveness of novel, lower cost molecular human papillomavirus-based tests for cervical cancer screening in rural china. Int J Cancer 2016, 138(6):1453-1461. doi: 10.1002/ijc.29877.

46.          Wang JB, Fan JH, Dawsey SM, Sinha R, Freedman ND, Taylor PR, Qiao YL, Abnet CC: Dietary components and risk of total, cancer and cardiovascular disease mortality in the Linxian Nutrition Intervention Trials cohort in China. Sci Rep 2016, 6:22619. doi: 10.1038/srep22619.

47.          Wang SM, Fan JH, Jia MM, Yang Z, Zhang YQ, Qiao YL, Taylor PR: Body mass index and long-term risk of death from esophageal squamous cell carcinoma in a Chinese population. Thorac Cancer 2016, 7(4):387-392. doi: 10.1111/1759-7714.12340.

48.          Yang Z, Holt HK, Fan JH, Ma L, Liu Y, Chen W, Como P, Zhang L, Qiao YL: Optimal Cutoff Scores for Alzheimer's Disease Using the Chinese Version of Mini-Mental State Examination Among Chinese Population Living in Rural Areas. Am J Alzheimers Dis Other Demen 2016, 31(8):650-657. doi: 10.1177/1533317516662336.

49.          Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ et al: Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Oncotarget 2016, 7(16):21181-21189. doi: 10.18632/oncotarget.8307.

50.          Yu LL, Guo HQ, Lei XQ, Qin Y, Wu ZN, Kang LN, Zhang X, Qiao YL, Chen W: p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China. Oncotarget 2016, 7(40):64810-64819. doi: 10.18632/oncotarget.11705.

51.          Yu LL, Kang LN, Zhao FH, Lei XQ, Qin Y, Wu ZN, Wang H, Chen W, Qiao YL: Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China. Cancer Epidemiol Biomarkers Prev 2016, 25(7):1167-1174. doi: 10.1158/1055-9965.Epi-15-1057.

52.          Yuan W, Tang W, Xie Y, Wang S, Chen Y, Qi J, Qiao Y, Ma J: New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer. Oncotarget 2016, 7(48):80033-80045. doi: 10.18632/oncotarget.12406.

53.          Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL et al: Risk assessment to guide cervical screening strategies in a large Chinese population. Int J Cancer 2016, 138(11):2639-2647. doi: 10.1002/ijc.30012.

54.          Zheng R, Zeng H, Zuo T, Zhang S, Qiao Y, Zhou Q, Chen W: Lung cancer incidence and mortality in China, 2011. Thorac Cancer 2016, 7(1):94-99. doi: 10.1111/1759-7714.12286.

55.          Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, Gupta PC, Sawada N, Tamakoshi A, Shu XO et al: Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia 2017, 60(6):1022-1032. doi: 10.1007/s00125-017-4229-z.

56.          Dong L, Hu SY, Zhang Q, Feng RM, Zhang L, Zhao XL, Zhang X, Qiao YL, Zhao FH: Risk Prediction of Cervical Cancer and Precancers by Type-Specific Human Papillomavirus: Evidence from a Population-Based Cohort Study in China. Cancer Prev Res (Phila) 2017, 10(12):745-751. doi: 10.1158/1940-6207.Capr-17-0088.

57.          Dong L, Lin C, Li L, Wang M, Cui J, Feng R, Liu B, Wu Z, Lian J, Liao G et al: An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium. J Clin Virol 2017, 94:67-71. doi: 10.1016/j.jcv.2017.06.008.

58.          Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR: Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort. Cancer Sci 2017, 108(8):1667-1672. doi: 10.1111/cas.13292.

59.          Fan JH, Zhang YQ, Shi SS, Chen YJ, Yuan XH, Jiang LM, Wang SM, Ma L, He YT, Feng CY et al: A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china. Oncotarget 2017, 8(42):71699-71708. doi: 10.18632/oncotarget.17599.

60.          Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G et al: Changing global policy to deliver safe, equitable, and affordable care for women's cancers. Lancet 2017, 389(10071):871-880. doi: 10.1016/s0140-6736(16)31393-9.

61.          Holt HK, Zhang L, Zhao FH, Hu SY, Zhao XL, Zhang X, Pan QJ, Zhang WH, Smith JS, Qiao YL: Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China. Int J Cancer 2017, 140(3):544-554. doi: 10.1002/ijc.30468.

62.          Hu SY, Zhang WH, Li SM, Li N, Huang MN, Pan QJ, Zhang X, Han Y, Zhao FH, Chen W et al: Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy. Medicine (Baltimore) 2017, 96(17):e6689. doi: 10.1097/md.0000000000006689.

63.          Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y et al: Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol 2017, 3(5):635-657. doi: 10.1200/jgo.2016.006577.

64.          Li Q, Yang Z, Fan J, He J, Zhang B, Yang H, Xie X, Tang Z, Li H, Qiao Y et al: A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients. Oncotarget 2017, 8(44):75864-75873. doi: 10.18632/oncotarget.16439.

65.          Li Y, Shi J, Yu S, Wang L, Liu J, Ren J, Gao S, Hui Z, Li J, Wu N et al: Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014. Cancer Med 2017, 6(10):2440-2452. doi: 10.1002/cam4.1170.

66.          Liang H, Fan JH, Qiao YL: Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med 2017, 14(1):33-41. doi: 10.20892/j.issn.2095-3941.2016.0093.

67.          Liang H, Yang Z, Wang JB, Yu P, Fan JH, Qiao YL, Taylor PR: Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial. Thorac Cancer 2017, 8(6):642-648. doi: 10.1111/1759-7714.12501.

68.          Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al: Correction for Lin et al., "Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test". J Clin Microbiol 2017, 55(6):1972. doi: 10.1128/jcm.00598-17.

69.          Lin CQ, Zeng X, Cui JF, Liao GD, Wu ZN, Gao QQ, Zhang X, Yu XZ, Chen W, Xi MR et al: Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test. J Clin Microbiol 2017, 55(2):568-573. doi: 10.1128/jcm.02025-16.

70.          Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, Kikuchi S, Inoue M, Tanaka H, He Y: Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol 2017, 27(3):215-221. doi: 10.1016/j.annepidem.2016.11.004.

71.          Liu Y, Zhang J, Huang R, Feng WL, Kong YN, Xu F, Zhao L, Song QK, Li J, Zhang BN et al: Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study. Medicine (Baltimore) 2017, 96(15):e6641. doi: 10.1097/md.0000000000006641.

72.          Song X, Li WQ, Hu N, Zhao XK, Wang Z, Hyland PL, Jiang T, Kong GQ, Su H, Wang C et al: GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer. Sci Rep 2017, 7(1):4642. doi: 10.1038/s41598-017-04822-2.

73.          Song Y, Zhao YQ, Li L, Pan QJ, Li N, Zhao FH, Chen W, Zhang X, Qiao YL: A retrospective analysis of the utility of endocervical curettage in screening population. Oncotarget 2017, 8(30):50141-50147. doi: 10.18632/oncotarget.15658.

74.          Wang M, Hu S, Zhao S, Zhang W, Pan Q, Zhang X, Chen F, Han J, Ma J, Smith JS et al: Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China. Chin J Cancer Res 2017, 29(6):496-509. doi: 10.21147/j.issn.1000-9604.2017.06.04.

75.          Wang Z, Dai J, Hu N, Miao X, Abnet CC, Yang M, Freedman ND, Chen J, Burdette L, Zhu X et al: Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. Gut 2017, 66(4):581-587. doi: 10.1136/gutjnl-2015-310612.

76.          Zhang J, Li X, Huang R, Feng WL, Kong YN, Xu F, Zhao L, Song QK, Li J, Zhang BN et al: A nomogram to predict the probability of axillary lymph node metastasis in female patients with breast cancer in China: A nationwide, multicenter, 10-year epidemiological study. Oncotarget 2017, 8(21):35311-35325. doi: 10.18632/oncotarget.13330.

77.          Zhang Q, Dong L, Hu S, Feng R, Zhang X, Pan Q, Ma J, Zhang L, Zhao X, Sankaranarayanan R et al: Risk stratification and long-term risk prediction of E6 oncoprotein in a prospective screening cohort in China. Int J Cancer 2017, 141(6):1110-1119. doi: 10.1002/ijc.30807.

78.          Chen W, Sun H, Molijn A, Zeng L, Kang L, Jenkins D, Zhang S, Cui J, Wu Z, Pirog E et al: The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China. J Low Genit Tract Dis 2018, 22(4):355-361. doi: 10.1097/lgt.0000000000000408.

79.          Dong L, Wang MZ, Zhao XL, Feng RM, Hu SY, Zhang Q, Smith JS, Qiao YL, Zhao FH: Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study. Gynecol Oncol 2018, 148(1):103-110. doi: 10.1016/j.ygyno.2017.11.016.

80.          Epplein M, Butt J, Zhang Y, Hendrix LH, Abnet CC, Murphy G, Zheng W, Shu XO, Tsugane S, Qiao YL et al: Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer. Cancer Epidemiol Biomarkers Prev 2018, 27(12):1472-1479. doi: 10.1158/1055-9965.Epi-18-0582.

81.          Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR: Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort. Heart 2018, 104(21):1764-1771. doi: 10.1136/heartjnl-2017-312850.

82.          Feng RM, M ZW, Smith JS, Dong L, Chen F, Pan QJ, Zhang X, Qiao YL, Zhao FH: Risk of high-risk human papillomavirus infection and cervical precancerous lesions with past or current trichomonas infection: a pooled analysis of 25,054 women in rural China. J Clin Virol 2018, 99-100:84-90. doi: 10.1016/j.jcv.2017.12.015.

83.          Hsieh E, Wang Q, Zhang R, Niu X, Xia W, Fraenkel L, Insogna KL, Li J, Smith JS, Zhou C et al: Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps. BMC Cancer 2018, 18(1):104. doi: 10.1186/s12885-018-4014-5.

84.          Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancela M, Gupta P, Meheus F, Qiao YL, Sitas F et al: Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison. Cancer Epidemiol 2018, 53:27-34. doi: 10.1016/j.canep.2017.12.013.

85.          Rezhake R, Hu SY, Zhao YQ, Zhang L, Zhao XL, Dominguez AZ, Qiao YL, Zhou CH, Zhao FH: Impact of International Collaborative Training Programs on Medical Students' Research Ability. J Cancer Educ 2018, 33(3):511-516. doi: 10.1007/s13187-016-1134-y.

86.          Thistle JE, Yang B, Petrick JL, Fan JH, Qiao YL, Abnet CC, Taylor PR, McGlynn KA: Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population. PLoS One 2018, 13(9):e0203926. doi: 10.1371/journal.pone.0203926.

87.          Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH et al: Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia. Dig Dis Sci 2018, 63(10):2765-2772. doi: 10.1007/s10620-018-5154-9.

88.          Wang SM, Fan JH, Taylor PR, Lam TK, Dawsey SM, Qiao YL, Abnet CC: Association of plasma vitamin C concentration to total and cause-specific mortality: a 16-year prospective study in China. J Epidemiol Community Health 2018, 72(12):1076-1082. doi: 10.1136/jech-2018-210809.

89.          Wang SM, Taylor PR, Fan JH, Pfeiffer RM, Gail MH, Liang H, Murphy GA, Dawsey SM, Qiao YL, Abnet CC: Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial. J Natl Cancer Inst 2018, 110(11):1229-1238. doi: 10.1093/jnci/djy043.

90.          Wong MCS, Hamilton W, Whiteman DC, Jiang JY, Qiao Y, Fung FDH, Wang HHX, Chiu PWY, Ng EKW, Wu JCY et al: Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries. Sci Rep 2018, 8(1):4522. doi: 10.1038/s41598-018-19819-8.

91.          Wu Z, Yu L, Lei X, Qin Y, Zhang X, Chen W, Qiao Y: The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer. J Clin Virol 2018, 108:6-11. doi: 10.1016/j.jcv.2018.08.008.

92.          Xue L, Hu W, Zhang H, Xie Z, Zhang X, Zhao F, Qiao Y, Gao L, Ma W: Awareness of and willingness to be vaccinated by human papillomavirus vaccine among junior middle school students in Jinan, China. Hum Vaccin Immunother 2018, 14(2):404-411. doi: 10.1080/21645515.2017.1393132.

93.          Yu L, Jiang M, Qu P, Wu Z, Sun P, Xi M, Qin Y, Liu X, Liao G, Lei X et al: Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage. Int J Cancer 2018, 143(4):813-822. doi: 10.1002/ijc.31368.

94.          Zhang L, Xu XQ, Hu SY, Chen F, Zhang X, Pan QJ, Zhang WH, Feng RM, Dong L, Zhang Q et al: Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China. Gynecol Oncol 2018, 151(2):221-228. doi: 10.1016/j.ygyno.2018.09.012.

95.          Zhang X, Lin X, Tan Y, Zhu Y, Wang H, Feng R, Tang G, Zhou X, Li A, Qiao Y: A multicenter hospital-based diagnosis study of automated breast ultrasound system in detecting breast cancer among Chinese women. Chin J Cancer Res 2018, 30(2):231-239. doi: 10.21147/j.issn.1000-9604.2018.02.06.

96.          Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim J et al: Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea. Cancer Prev Res (Phila) 2019, 12(10):667-674. doi: 10.1158/1940-6207.Capr-19-0238.

97.          Chen W, Zhao Y, Xie X, Liu J, Li J, Zhao C, Wang S, Liao X, Shou Q, Zheng M et al: Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90?months of follow-up. Vaccine 2019, 37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030.

98.          Dong L, Li T, Li L, Wang MZ, Wu Z, Cui J, Liu B, Zhang X, Qiao Y, Chen W: Clustering patterns of type-type combination in multiple genotypes infections of human papillomavirus in cervical adenocarcinoma. J Med Virol 2019, 91(11):2001-2008. doi: 10.1002/jmv.25553.

99.          Guo L, Zhang S, Liu S, Zheng L, Chen Q, Cao X, Sun X, Qiao Y, Zhang J: Determinants of participation and detection rate of upper gastrointestinal cancer from population-based screening program in China. Cancer Med 2019, 8(16):7098-7107. doi: 10.1002/cam4.2578.

100.        Hou DH, Zhao SJ, Shi JF, Wang L, Wang DB, Huang YC, Liao XZ, Xing XJ, Du LB, Yang L et al: Lung cancer imaging methods in China from 2005 to 2014: A national, multicenter study. Thorac Cancer 2019, 10(4):708-714. doi: 10.1111/1759-7714.12988.

101.        Li Y, Ma L, Yang C, Chen Z, Zhao Y, Dang L, Lang J, Qiao Y: A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China. Chin J Cancer Res 2019, 31(5):838-848. doi: 10.21147/j.issn.1000-9604.2019.05.13.

102.        Liu YJ, Keane A, Simms KT, Lew JB, Shi JF, Mazariego C, Yuill S, Jeronimo J, Qiao YL, Canfell K: Development and application of a framework to estimate health care costs in China: The cervical cancer example. PLoS One 2019, 14(10):e0222760. doi: 10.1371/journal.pone.0222760.

103.        Ma L, Wang Y, Gao X, Dai Y, Zhang Y, Wang Z, Wang X, Wang L, Jiang J, Jing X et al: Economic evaluation of cervical cancer screening strategies in urban China. Chin J Cancer Res 2019, 31(6):974-983. doi: 10.21147/j.issn.1000-9604.2019.06.13.

104.        Men Y, Wang L, Zhang Y, Gao S, Li J, Wu N, Yang B, Liu S, Ren J, Huang Y et al: Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study. Front Oncol 2019, 9:786. doi: 10.3389/fonc.2019.00786.

105.        Pretorius RG, Belinson JL, Burchette RJ, Wu R, Qiao YL: Key Determinants of the Value of Random Cervical Biopsy at Colposcopy. J Low Genit Tract Dis 2019, 23(4):241-247. doi: 10.1097/lgt.0000000000000485.

106.        Rezhake R, Hu SY, Zhao S, Xu XQ, Zhao XL, Zhang L, Wang Y, Zhang X, Pan QJ, Qiao YL et al: Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women. Int J Cancer 2019, 144(1):34-42. doi: 10.1002/ijc.31633.

107.        Rezhake R, Xu XQ, Montigny S, Berger A, Hu SY, Liu ZH, Sankaranarayanan R, Qiao YL, Basu P, Zhao FH: Training Future Leaders: Experience from China-ASEAN Cancer Control Training Program. J Cancer Educ 2019, 34(6):1067-1073. doi: 10.1007/s13187-018-1409-6.

108.        Shi JF, Wang L, Wu N, Li JL, Hui ZG, Liu SM, Yang BY, Gao SG, Ren JS, Huang HY et al: Clinical characteristics and medical service utilization of lung cancer in China, 2005-2014: Overall design and results from a multicenter retrospective epidemiologic survey. Lung Cancer 2019, 128:91-100. doi: 10.1016/j.lungcan.2018.11.031.

109.        Si M, Su X, Jiang Y, Qiao Y, Liu Y: Interventions to improve human papillomavirus vaccination among Chinese female college students: study protocol for a randomized controlled trial. BMC Public Health 2019, 19(1):1546. doi: 10.1186/s12889-019-7903-x.

110.        Su B, Luo P, Yang Z, Yu P, Li Z, Yin P, Zhou L, Fan J, Huang X, Lin X et al: A novel analysis method for biomarker identification based on horizontal relationship: identifying potential biomarkers from large-scale hepatocellular carcinoma metabolomics data. Anal Bioanal Chem 2019, 411(24):6377-6386. doi: 10.1007/s00216-019-02011-w.

111.         Totsuka Y, Lin Y, He Y, Ishino K, Sato H, Kato M, Nagai M, Elzawahry A, Totoki Y, Nakamura H et al: DNA Adductome Analysis Identifies N-Nitrosopiperidine Involved in the Etiology of Esophageal Cancer in Cixian, China. Chem Res Toxicol 2019, 32(8):1515-1527. doi: 10.1021/acs.chemrestox.9b00017.

112.        Wang MZ, Feng RM, Wang S, Duan XZ, Li D, Zhang X, Mu R, Qiao Y, Smith JS: Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China. Sex Transm Dis 2019, 46(8):540-547. doi: 10.1097/olq.0000000000001026.

113.        Wang SM, Abnet CC, Qiao YL: What have we learned from Linxian esophageal cancer etiological studies? Thorac Cancer 2019, 10(5):1036-1042. doi: 10.1111/1759-7714.13058.

114.        Wang SM, Roth MJ, Murphy GA, Dawsey SM, Fan JH, Taylor PR, Qiao YL, Abnet CC: Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and H. pylori and Risk of Upper Gastrointestinal Cancer: A Nested Case-Control Study in China. Cancer Epidemiol Biomarkers Prev 2019, 28(12):2022-2029. doi: 10.1158/1055-9965.Epi-19-0512.

115.        Wei L, Xie X, Liu J, Zhao Y, Chen W, Zhao C, Wang S, Liao X, Shou Q, Qiu Y et al: Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up. Vaccine 2019, 37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009.

116.        Wu Z, Li TY, Jiang M, Yu L, Zhao J, Wang H, Zhang X, Chen W, Qiao Y: Human Papillomavirus (HPV) 16/18 E6 Oncoprotein Expression in Infections with Single and Multiple Genotypes. Cancer Prev Res (Phila) 2019, 12(2):95-102. doi: 10.1158/1940-6207.Capr-18-0343.

117.        Xia C, Hu S, Xu X, Zhao X, Qiao Y, Broutet N, Canfell K, Hutubessy R, Zhao F: Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health 2019, 4(9):e462-e472. doi: 10.1016/s2468-2667(19)30162-8.

118.        Xing PY, Zhu YX, Wang L, Hui ZG, Liu SM, Ren JS, Zhang Y, Song Y, Liu CC, Huang YC et al: What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China. Cancer Med 2019, 8(8):4055-4069. doi: 10.1002/cam4.2256.

119.        Yang JJ, Yu D, Wen W, Saito E, Rahman S, Shu XO, Chen Y, Gupta PC, Gu D, Tsugane S et al: Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants. JAMA Netw Open 2019, 2(4):e192696. doi: 10.1001/jamanetworkopen.2019.2696.

120.        Yang JJ, Yu D, Wen W, Shu XO, Saito E, Rahman S, Gupta PC, He J, Tsugane S, Xiang YB et al: Tobacco Smoking and Mortality in Asia: A Pooled Meta-analysis. JAMA Netw Open 2019, 2(3):e191474. doi: 10.1001/jamanetworkopen.2019.1474.

121.        Zhang H, Xie P, Li Z, Huang R, Feng W, Kong Y, Xu F, Zhao L, Song Q, Li J et al: A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study. Diagn Pathol 2019, 14(1):35. doi: 10.1186/s13000-019-0806-4.

122.        Zhang S, Yu P, Wang JB, Fan JH, Qiao YL, Taylor PR: Association between tooth loss and upper gastrointestinal cancer: A 30-year follow-up of the Linxian Dysplasia Nutrition Intervention Trial Cohort. Thorac Cancer 2019, 10(4):966-974. doi: 10.1111/1759-7714.13037.

123.        Zhao F, Qiao Y: Cervical cancer prevention in China: a key to cancer control. Lancet 2019, 393(10175):969-970. doi: 10.1016/s0140-6736(18)32849-6.

124.        Chen H, Zhang X, Wang W, Zhang R, Du M, Shan L, Li Y, Wang X, Liu Y, Zhang W et al: Effect of an educational intervention on human papillomavirus (HPV) knowledge and attitudes towards HPV vaccines among healthcare workers (HCWs) in Western China. Hum Vaccin Immunother 2020:1-8. doi: 10.1080/21645515.2020.1780093.

125.        Chua GT, Ho FK, Tung KT, Wong RS, Cheong KN, Yip PS, Fan SY, Wong WH, Qiao Y, Chui CS et al: Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females. Vaccine 2020, 38(5):1025-1031. doi: 10.1016/j.vaccine.2019.11.044.

126.        Dong L, Zhang L, Hu SY, Feng RM, Zhao XL, Zhang Q, Pan QJ, Zhang X, Qiao YL, Zhao FH: Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study. Clin Epigenetics 2020, 12(1):62. doi: 10.1186/s13148-020-00853-1.

127.        Duan R, Qiao Y, Clifford G, Zhao F: Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. Cancer Med 2020, 9(1):374-384. doi: 10.1002/cam4.2697.

128.        Feng H, Song G, Ma S, Ma Q, Li X, Wei W, Abnet C, Qiao Y, Wang G: The optimal starting age of endoscopic screening for esophageal squamous cell cancer in high prevalence areas in China. J Gastroenterol Hepatol 2020, 35(10):1761-1768. doi: 10.1111/jgh.15090.

129.        Hu SY, Rezhake R, Chen F, Zhang X, Pan QJ, Ma JF, Qiao YL, Zhao FH: Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China. Gynecol Oncol 2020, 156(3):616-623. doi: 10.1016/j.ygyno.2019.12.027.

130.        Jang J, Wang T, Cai H, Ye F, Murphy G, Shimazu T, Taylor PR, Qiao YL, Yoo KY, Jee SH et al: The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies. Int J Cancer 2020, 147(3):777-784. doi: 10.1002/ijc.32790.

131.        Jia M, Lin X, Zhou X, Yan H, Chen Y, Liu P, Bao L, Li A, Basu P, Qiao Y et al: Diagnostic performance of automated breast ultrasound and handheld ultrasound in women with dense breasts. Breast Cancer Res Treat 2020, 181(3):589-597. doi: 10.1007/s10549-020-05625-2.

132.        Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X et al: Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women. Cancer Prev Res (Phila) 2020, 13(2):163-172. doi: 10.1158/1940-6207.Capr-19-0144.

133.        Li T, Wu Z, Jiang M, Zhao Y, Yu L, Qin Y, Liu B, Cui J, Li L, Pan Q et al: Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women. Gynecol Oncol 2020, 157(1):202-208. doi: 10.1016/j.ygyno.2020.01.011.

134.        Li Y, Chen J, Xue P, Tang C, Chang J, Chu C, Ma K, Li Q, Zheng Y, Qiao Y: Computer-aided Cervical Cancer Diagnosis using Time-lapsed Colposcopic Images. IEEE Trans Med Imaging 2020, Pp. doi: 10.1109/tmi.2020.2994778.

135.        Lin X, Jia M, Zhou X, Bao L, Chen Y, Liu P, Feng R, Zhang X, Zhu L, Wang H et al: The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China. Eur Radiol 2020. doi: 10.1007/s00330-020-07197-7.

136.        Naizhaer G, Yuan J, Mijiti P, Aierken K, Abulizi G, Qiao Y: Evaluation of multiple screening methods for cervical cancers in rural areas of Xinjiang, China. Medicine (Baltimore) 2020, 99(6):e19135. doi: 10.1097/md.0000000000019135.

137.        Pritchett NR, Maziarz M, Shu XO, Kamangar F, Dawsey SM, Fan JH, Ji BT, Gao YT, Xiang YB, Qiao YL et al: Serum ghrelin and esophageal and gastric cancer in two cohorts in China. Int J Cancer 2020, 146(10):2728-2735. doi: 10.1002/ijc.32597.

138.        Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ et al: Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. J Natl Cancer Inst 2020, 112(2):145-153. doi: 10.1093/jnci/djz074.

139.        Rezhake R, Chen F, Hu SY, Zhao XL, Zhang X, Cao J, Qiao YL, Zhao FH, Arbyn M: Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China. Int J Cancer 2020, 147(8):2053-2064. doi: 10.1002/ijc.33001.

140.        Si MY, Su XY, Jiang Y, Wang WJ, Gu XF, Ma L, Li J, Zhang SK, Ren ZF, Ren R et al: Psychological impact of COVID-19 on medical care workers in China. Infect Dis Poverty 2020, 9(1):113. doi: 10.1186/s40249-020-00724-0.

141.        Su YY, Lin BZ, Zhao H, Li J, Lin ZJ, Qiao YL, Wei LH, Hu YM, Li RC, Zhuang SJ et al: Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial. Hum Vaccin Immunother 2020, 16(7):1636-1644. doi: 10.1080/21645515.2019.1691413.

142.        Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, Leung J, Ravindran AV, Chen WQ, Qiao YL et al: Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry 2020, 25(7):1487-1499. doi: 10.1038/s41380-019-0595-x.

143.        Wei MN, Su Z, Wang JN, Gonzalez Mendez MJ, Yu XY, Liang H, Zhou QH, Fan YG, Qiao YL: Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study. Thorac Cancer 2020, 11(5):1224-1232. doi: 10.1111/1759-7714.13379.

144.        Wei WQ, Hao CQ, Guan CT, Song GH, Wang M, Zhao DL, Li BY, Bai WL, Hou PY, Wang JW et al: Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. Am J Gastroenterol 2020, 115(7):1036-1044. doi: 10.14309/ajg.0000000000000640.

145.        Xing PY, Wang SZ, Shi JF, Wang L, Hui ZG, Ren JS, Liu SM, Qiao YL, Dai M, Li JL: Changes and Influential Factors of Chemotherapy Usage for Non-Small Cell Lung Cancer Patients in China: A Multicenter 10-Year (2005-2014) Retrospective Study. Cancer Manag Res 2020, 12:6033-6044. doi: 10.2147/cmar.S253789.

146.        Xu H, Gonzalez MJ, Guo L, Chen Q, Zheng L, Chen P, Cao X, Liu S, Sun X, Zhang S et al: Knowledge, Awareness, and Attitudes Towards COVID-19 Pandemic Among Different Populations in Central China: A Cross-Sectional Survey. J Med Internet Res 2020. doi: 10.2196/22628.

147.        Xu H, Yu Y, George W, Smith JS, Hu S, Dang L, Zhang X, Pan Q, Qiao Y, Zhao F: Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population. J Med Virol 2020, 92(2):234-240. doi: 10.1002/jmv.25597.

148.        Xue P, Ng MTA, Qiao Y: The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC Med 2020, 18(1):169. doi: 10.1186/s12916-020-01613-x.

149.        Yang H, Zhang S, Wang J, Fan J, Qiao Y, Taylor PR: Oral leukoplakia and the long-term risk of upper gastrointestinal cancer deaths in the Linxian dysplasia population. Thorac Cancer 2020, 11(10):2804-2811. doi: 10.1111/1759-7714.13595.

150.        Yang H, Zhang S, Yan H, Wang J, Fan J, Qiao Y, Taylor PR: Fresh fruit consumption may decrease the long-term risk of esophageal cancer mortality: A 30-year follow-up study in the Linxian Dysplasia Nutrition Intervention trial (NIT). Thorac Cancer 2020, 11(7):1918-1926. doi: 10.1111/1759-7714.13482.

151.        Yi ZB, Yu P, Zhang S, Wang WN, Han YQ, Ouyang QC, Yan M, Wang XJ, Hu XC, Jiang ZF et al: Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study. Int J Cancer 2020. doi: 10.1002/ijc.33227.

152.        Yin J, Yin LY, Freedman ND, Li TY, Dawsey SM, Cui JF, Taylor PR, Liu B, Fan JH, Chen W et al: Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case-Control Study. Cancer Epidemiol Biomarkers Prev 2020, 29(10):2057-2064. doi: 10.1158/1055-9965.Epi-20-0417.

153.        Yu XJ, Li J, Lin ZJ, Zhao H, Lin BZ, Qiao YL, Hu YM, Wei LH, Li RC, Huang WD et al: Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals. Hum Vaccin Immunother 2020, 16(7):1630-1635. doi: 10.1080/21645515.2020.1761202.

154.        Zhang DY, Chen W, Zhang HY, Lv SQ, Lu XN, Tao YP, Zhang M, Liu JF, Yang M, Qiao YL et al: Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China. Kaohsiung J Med Sci 2020, 36(6):450-459. doi: 10.1002/kjm2.12175.

155.        Zhang J, Xu H, Zheng L, Yu J, Chen Q, Cao X, Liu S, Jose Gonzalez M, Guo L, Sun X et al: Determinants of Participation and Detection Rate of Colorectal Cancer From a Population-Based Screening Program in China. Front Oncol 2020, 10:1173. doi: 10.3389/fonc.2020.01173.

156.        Zhang S, Wang JB, Yang H, Fan JH, Qiao YL, Taylor PR: Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort. Cancer Epidemiol 2020, 65:101683. doi: 10.1016/j.canep.2020.101683.

157.        Zhang X, Liu CR, Wang ZZ, Ren ZF, Feng XX, Ma W, Gao XH, Zhang R, Brown MD, Qiao YL et al: Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study. Vaccine 2020, 38(20):3665-3670. doi: 10.1016/j.vaccine.2020.03.032.

158.        Zhao F, Wen Y, Li Y, Tao S, Ma L, Zhao Y, Dang L, Wang Y, Zhao F, Lang J et al: Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China. Asian Pac J Cancer Prev 2020, 21(5):1317-1325. doi: 10.31557/apjcp.2020.21.5.1317.

159.        Zhao XL, Liu ZH, Zhao S, Hu SY, Muwonge R, Duan XZ, Du LJ, Su CF, Xiang XE, Zhang X et al: Efficacy of point-of-care thermal ablation among high-risk human papillomavirus positive women in China. Int J Cancer 2020. doi: 10.1002/ijc.33290.

160.        Zhao XL, Xu XQ, Duan XZ, Rezhake R, Hu SY, Wang Y, Xia CF, Zhang X, Qiao YL, Sankaranarayanan R et al: Comparative performance evaluation of different HPV tests and triaging strategies using self-samples and feasibility assessment of thermal ablation in 'colposcopy and treat' approach: A population-based study in rural China. Int J Cancer 2020, 147(5):1275-1285. doi: 10.1002/ijc.32881.

161.        Zhao Y, Zhao F, Hu S, Zhang X, Zhang W, Pan Q, Gage JC, Sankaranarayanan R, Qiao Y: Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies. Chin J Cancer Res 2020, 32(3):383-394. doi: 10.21147/j.issn.1000-9604.2020.03.09.

二、中文文章

 [1]    曾晓敏, 任泽舫, 魏雪灵, et al. 中山大学本科生对HPV及疫苗认知的调查 [J]. 现代预防医学, 2015, 42(10): 1822-5.

[2]    段仙芝, 宋艳波, 王少明, et al. 宫颈液基细胞学结果与高危型人乳头瘤病毒的相关性 [J]. 中国肿瘤, 2015, 24(01): 76-80.

[3]    飞秋月, 张红芸, 徐琳, et al. HIV感染妇女宫颈疾病中P16INK4a蛋白的表达 [J]. 昆明医科大学学报, 2015, 36(12): 134-8.

[4]    冯昊, 宋国慧, 杨娟, et al. 中国农村食管癌高发区人群终生一次内镜筛查适宜年龄的卫生经济学评价 [J]. 中华肿瘤杂志, 2015, 37(06): 476-80.

[5]    李纪宾, 乔友林. 城市宫颈癌防治经验探索——深圳宫颈癌防治10年 [J]. 中国肿瘤, 2015, 24(12): 971-2.

[6]    李雨聪, 张莉, 胡尚英, et al. 高危型人乳头瘤病毒检测初筛宫颈癌后几种分流方法的效果评价 [J]. 肿瘤, 2015, 35(05): 536-43.

[7]    乔友林. 适宜发展中国家与地区的宫颈癌快速筛查技术的研究及意义 [J]. 中华预防医学杂志, 2015, 49(02): 110-1.

[8]    乔友林, 于露露. 人乳头瘤病毒在子宫颈癌筛查中的意义和作用 [J]. 妇产与遗传(电子版), 2015, 5(03): 7-11.

[9]    乔友林, 赵宇倩. 宫颈癌的流行病学现状和预防 [J]. 中华妇幼临床医学杂志(电子版), 2015, 11(02): 1-6.

[10]  王孟, 乔友林. 终生一次内镜筛查降低食管癌累计发病率和死亡率 [J]. 循证医学, 2015, 15(04): 210.

[11]  王少明, 范金虎, 张雨晴, et al. 甲状腺肿可能增加胃癌的死亡风险——林县营养干预试验27年随访结果 [J]. 中国肿瘤, 2015, 24(06): 439-43.

[12]  魏文强, 乔友林. 食管癌预防医学的重要研究进展 [J]. 浙江医学, 2015, 37(10): 808.

[13]  严毅, 王晓辉, 王玉, et al. 甘肃武都农村妇女HPV感染、CIN病变与P16~(INK4A)表达相关性分析 [J]. 中华疾病控制杂志, 2015, 19(11): 1171-3.

[14]  张柏林, 张倩, G.SIVASUBRAMANIAM P, et al. 中国年轻乳腺癌发病危险因素——多中心十年回顾性研究 [J]. 中国肿瘤, 2015, 24(12): 1042-7.

[15]  张欢欢, 王少明, 乔友林, et al. 人乳头瘤状病毒预防性疫苗研发现状及应用中存在的问题 [J]. 山东医药, 2015, 55(35): 97-9.

[16]  赵宇倩, 宋艳, 赵方辉, et al. 阴道镜下四象限活检在宫颈癌前病变筛查中的价值 [J]. 中华肿瘤杂志, 2015, 37(11): 875-9.

[17]  赵宇倩, 赵方辉, 胡尚英, et al. 中国女性人群宫颈人乳头瘤病毒感染及型别分布的多中心横断面研究 [J]. 中华流行病学杂志, 2015, 36(12): 1351-6.

[18]  董丽, 乔友林. 宫颈腺癌与HPV [J]. 实用妇产科杂志, 2016, 32(08): 561-2.

[19]  何红艳, 王少明, 乔友林, et al. 几种人乳头瘤病毒检测方法的研究 [J]. 中外女性健康研究, 2016, 04): 12-3 5.

[20]  刘妞, 胡尚英, 张倩, et al. 全球子宫颈癌筛查指南析评 [J]. 癌症进展, 2016, 14(12): 1210-2.

[21]  乔友林. 食管癌流行病学研究的重要里程碑 [J]. 中国肿瘤临床, 2016, 43(12): 500-1.

[22]  孙小伟, 郑凤仙, 刘金红, et al. 国产HPV杂交捕获技术在农村宫颈癌筛查中的应用 [J]. 中华肿瘤防治杂志, 2016, 23(03): 137-41.

[23]  杨召, 王少明, 梁赫, et al. 竞争风险型数据统计分析理论研究进展 [J]. 中国卫生统计, 2016, 33(06): 1088-91.

[24]  杨召, 王少明, 梁赫, et al. 新鲜水果摄入可能降低食管癌长期死亡风险 [J]. 中国肿瘤临床, 2016, 43(18): 808-13.

[25]  张保宁, 陈万青, 张希, et al. 中国乳腺癌防控形势面临挑战 [J]. 中华肿瘤杂志, 2016, 38(10): 798-800.

[26]  张莉, 冯瑞梅, 胡尚英, et al. 细胞学检测为非典型鳞状细胞且人乳头瘤病毒阴性妇女的宫颈癌患病风险评估 [J]. 中华流行病学杂志, 2016, 37(06): 801-4.

[27]  张倩, 胡尚英, 冯瑞梅, et al. 高危型人乳头瘤病毒感染变化与宫颈癌及癌前病变发病风险的15年前瞻队列随访研究 [J]. 中华肿瘤杂志, 2016, 38(10): 792-7.

[28]  张雨晴, 马莉, 贺宇彤, et al. 2001~2010年中国胰腺神经内分泌肿瘤的临床流行病学特征分析 [J]. 中国肿瘤, 2016, 25(05): 329-33.

[29]  周清华, 范亚光, 王颖, et al. 中国肺部结节分类、诊断与治疗指南(2016年版) [J]. 中国肺癌杂志, 2016, 19(12): 793-8.

[30]  党乐, 马俊飞, 郭董平, et al. 我国农村地区宫颈癌筛查中人乳头瘤病毒检测阳性女性的分流策略 [J]. 中国肿瘤临床与康复, 2017, 24(03): 257-61.

[31]  董丽, 胡尚英, 张倩, et al. 山西省宫颈癌筛查队列中人乳头瘤病毒基因型别分布10年动态变化规律研究 [J]. 中华流行病学杂志, 2017, 38(01): 20-5.

[32]  范振列, 杨召, 乔友林, et al. 109例直肠神经内分泌肿瘤患者的临床病理特征与预后分析 [J]. 中国肿瘤, 2017, 26(04): 308-14.

[33]  冯瑞梅, 陈汶, 乔友林. 高危型人乳头瘤病毒核酸体外检测试剂盒临床功能验证的中美指导原则解读 [J]. 中华肿瘤杂志, 2017, 39(07): 553-7.

[34]  管晨滔, 赵宏, 李新庆, et al. 肝细胞癌患者的基本特征及其生存分析 [J]. 中华肿瘤杂志, 2017, 39(03): 231-5.

[35]  胡尚英, 热米拉·热扎克, 张倩, et al. HPV16/18 DNA分型对宫颈细胞学ASC-US女性的风险分层管理作用研究 [J]. 肿瘤学杂志, 2017, 23(09): 780-4.

[36]  梁赫, 王少明, 杨召, et al. 新鲜水果可能降低男性吸烟人群中食管癌的长期死亡风险:林县营养干预试验30年随访研究 [J]. 中国肿瘤, 2017, 26(12): 953-9.

[37]  刘妞, 张希, 党乐, et al. 内蒙古自治区鄂尔多斯市汉族和蒙古族女性乳腺癌筛查认知及意愿调查 [J]. 肿瘤研究与临床, 2017, 29(03): 191-6.

[38]  史少东, 贾萌萌, 王少明, et al. 山西省襄垣县2009～2015年农村女性宫颈癌筛查项目结果分析 [J]. 中国肿瘤, 2017, 26(07): 536-9.

[39]  王海瑞, 廖光东, 陈汶, et al. p16/Ki-67免疫细胞化学双染在宫颈癌筛查中的应用价值 [J]. 中华肿瘤杂志, 2017, 39(08): 636-40.

[40]  王海瑞, 廖光东, 江宇, et al. p16/mcm2双染在宫颈上皮内瘤变的诊断价值及其与高危型HPV感染的关系 [J]. 中华流行病学杂志, 2017, 38(09): 1241-5.

[41]  王轶英, 王悦, 乔友林, et al. 中国宫颈癌筛查未来之路——细胞学初筛的弃或守 [J]. 中国实用妇科与产科杂志, 2017, 33(03): 324-6.

[42]  闫宇, 任予, 范金虎, et al. 65岁以上中国老年女性原发性乳腺癌临床病理特征及治疗分析:多中心10年回顾性研究 [J]. 中国肿瘤, 2017, 26(07): 561-6.

[43]  郑凤仙, 孙小伟, 李彩红, et al. HPV检测技术初筛巴氏涂片分流应用于农村女性宫颈癌筛查效果 [J]. 中华疾病控制杂志, 2017, 21(05): 492-5 500.

[44]  富诗岚, 余艳琴, 徐慧芳, et al. 中国大陆人群对人乳头瘤病毒预防性疫苗的认知和态度 [J]. 中国肿瘤临床, 2018, 45(23): 1220-4.

[45]  胡尚英, 乔友林. 2017年WHO HPV疫苗立场文件的解读 [J]. 中华预防医学杂志, 2018, 52(05): 464-8.

[46]  姜明月, 冯瑞梅, 王林, et al. 液基细胞学联合人乳头状瘤病毒核酸检测对宫颈癌筛查的效果评价 [J]. 中华肿瘤杂志, 2018, 40(10): 750-6.

[47]  李莉, 王林, 李菊晓, et al. 宫颈细胞内p16/Ki67表达与宫颈癌及癌前病变的关系及其用于HPV阳性人群分流的诊断价值 [J]. 中国肿瘤, 2018, 27(04): 311-5.

[48]  李莉, 王林, 李志芳, et al. Aptima HPV E6/E7mRNA技术检出宫颈癌及癌前病变的临床效果研究 [J]. 中国妇产科临床杂志, 2018, 19(04): 341-4.

[49]  林威, 刘植华, 王月云, et al. 深圳女性子宫颈人乳头瘤病毒感染型别分布情况 [J]. 中国热带医学, 2018, 18(11): 1088-90 94.

[50]  刘植华, 林威, 王月云, et al. 高危型人乳头状瘤病毒风险分层在深圳地区人乳头状瘤病毒初筛阳性人群分流中的应用 [J]. 中华肿瘤杂志, 2018, 40(10): 757-63.

[51]  乔友林. 中国宫颈癌防治任重而道远 [J]. 中华肿瘤杂志, 2018, 40(10): 721-3.

[52]  热米拉·热扎克, 朱之恺, 张倩, et al. 不同介质标本中人乳头瘤病毒E6癌蛋白检测效果对比研究 [J]. 病毒学报, 2018, 34(05): 549-54.

[53]  陶思源, 彭介入, 王英, et al. 子宫颈癌及癌前病变患者直接经济负担及其影响因素研究 [J]. 中华预防医学杂志, 2018, 52(12): 1281-6.

[54]  王月云, 林威, 吴波, et al. 2014—2016年深圳市子宫颈癌筛查中HPV阳性者HPV高危亚型分布及相关因素 [J]. 中华预防医学杂志, 2018, 52(05): 480-5.

[55]  王月云, 唐朝, 刘植华, et al. 深圳市女性子宫颈人乳头瘤病毒感染危险因素分析 [J]. 中国热带医学, 2018, 18(11): 1083-7.

[56]  魏丽惠, 乔友林. 《预防子宫颈癌百问百答》 [J]. 出版参考, 2018, 10): 2.

[57]  吴泽妮, 苏征, 陈汶, et al. 人乳头状瘤病毒检测在28 923例不能明确意义的不典型鳞状细胞患者中的应用:中国104项研究汇总分析 [J]. 中华病理学杂志, 2018, 47(04): 269-73.

[58]  徐小倩, 张莉, 胡尚英, et al. HPV载量在阴道镜下随机活检中的作用分析 [J]. 中华预防医学杂志, 2018, 52(05): 475-9.

[59]  薛鹏, 乔友林, 江宇. 人工智能在医学内窥镜诊断中的应用 [J]. 中华肿瘤杂志, 2018, 40(12): 890-3.

[60]  余艳琴, 贾萌萌, 郝金奇, et al. 中国女性三阴性乳腺癌发病相关因素的Meta分析 [J]. 中国肿瘤, 2018, 27(11): 881-8.

[61]  余艳琴, 乔友林. 中国HPV预防性疫苗防治宫颈癌的应用前景 [J]. 肿瘤预防与治疗, 2018, 31(04): 237-41.

[62]  张爱爱, 党乐, 何涛, et al. 汉族和蒙古族女性宫颈癌筛查认知意愿和疫苗接受度调查 [J]. 中国肿瘤临床与康复, 2018, 25(10): 1153-8.

[63]  张莉, 李佳瑶, 热米拉·热扎克, et al. hrHPV DNA载量 分型和E6蛋白对宫颈癌前病变进展的预测作用 [J]. 中国肿瘤临床, 2018, 45(17): 878-82.

[64]  赵静, 李芹, 曹雪芳, et al. 云南新平县女性阴道微生态异常与HR-HPV的相关性研究 [J]. 中国热带医学, 2018, 18(12): 1222-5.

[65]  赵宇倩, 戴毅, 党乐, et al. 适合中国人群的宫颈癌筛查技术和效果评价的真实世界研究 [J]. 中华肿瘤杂志, 2018, 40(10): 764-71.

[66]  周清华, 范亚光, 王颖, et al. 中国肺癌低剂量螺旋CT筛查指南(2018年版) [J]. 中国肺癌杂志, 2018, 21(02): 67-75.

[67]  李扬, 陈张娅, 赵宇倩, et al. 中国部分地区子宫颈癌筛查的多中心成本测算研究 [J]. 中国医药导报, 2019, 16(32): 22-6.

[68]  梁青壮, 韦伟, 陈汶, et al. 鼻腔鼻窦内翻性乳头状瘤恶变鳞状细胞癌中HPV的分布及预后分析 [J]. 中国耳鼻咽喉颅底外科杂志, 2019, 25(02): 172-6.

[69]  卢宪中, 茅艺伟, 乔友林, et al. 宫颈癌公共筛查策略的经济学评价 [J]. 中国药物经济学, 2019, 14(03): 5-10.

[70]  彭介入, 陶思源, 温莹, et al. 中国城镇地区子宫颈癌筛查的卫生经济学评价 [J]. 中华肿瘤杂志, 2019, 02): 154-60.

[71]  乔友林, 赵方辉. 首个国产子宫颈癌疫苗获批上市，售价仅为同种进口疫苗的一半 [J]. 抗癌之窗, 2019, 06): 6-7.

[72]  王鹏, 郭珍, 赵冬梅, et al. 高危型人乳头瘤病毒E6/E7 mRNA对未明确意义的非典型鳞状上皮细胞人群分流的意义 [J]. 中国肿瘤, 2019, 28(11): 876-82.

[73]  王玉莹, 王兆京, 张瑜, et al. 中国农村15种子宫颈癌筛查方案的卫生经济学评价 [J]. 中华妇产科杂志, 2019, 12): 840-1-2-3-4-5-6-7.

[74]  徐慧芳, 乔友林. 尿液HPV检测的研究进展 [J]. 中国肿瘤, 2019, 28(09): 705-9.

[75]  薛鹏, 沈洁, 李莉, et al. HPV E6/E7 mRNA和HPV DNA检测技术在宫颈上皮内瘤变中的诊断价值分析 [J]. 癌症进展, 2019, 17(10): 1160-3 77.

[76]  薛鹏, 唐朝, 乔友林, et al. 人工智能电子阴道镜辅助诊断系统对宫颈癌筛查的现实挑战和未来机遇 [J]. 中国肿瘤, 2019, 28(07): 483-6.

[77]  于佩, 梁赫, 易宗毕, et al. 影响中国华北地区女性乳腺癌无病生存期的临床病理因素——多中心回顾性研究 [J]. 中国肿瘤, 2019, 28(04): 315-20.

[78]  余艳琴, 富诗岚, 徐慧芳, et al. 中国大陆女性体检人群中人乳头瘤病毒型别感染率及九价疫苗中HPV各型别分布的系统评价 [J]. 肿瘤预防与治疗, 2019, 32(02): 103-13.

[79]  余艳琴, 乔友林. 人群肿瘤环境危险因素归因危险度概述 [J]. 现代预防医学, 2019, 46(01): 162-5 75.

[80]  张莉, 热米拉·热扎克, 胡尚英, et al. 阴道镜结果正常或低度病变妇女发生宫颈癌前病变的前瞻性风险分层研究 [J]. 中国肿瘤临床, 2019, 46(15): 768-72.

[81]  罗贤懋, 林培中, 刘雨菁, et al. 核黄素预防恶性肿瘤的研究进展 [J]. 癌症进展, 2020, 18(04): 325-30.

[82]  王鹏, 郭珍, 赵冬梅, et al. 高危型HPV分型检测对早期宫颈癌诊断的意义 [J]. 中华医学杂志, 2020, 18): 1396-7-8-9-400.

[83]  韦梦娜, 余艳琴, 徐慧芳, et al. 中国大陆地区不同宫颈病变人群中人乳头瘤病毒感染率及型别分布的系统研究 [J]. 中国肿瘤临床与康复, 2020, 27(02): 133-7.

[84]  徐慧芳, 余艳琴, 邵晨轶, et al. DH3与cobas4800在宫颈癌筛查中的效果对比研究 [J]. 中国肿瘤临床与康复, 2020, 27(02): 129-32.

[85]  薛鹏, 沈洁, 韩历丽, et al. 国内人乳头瘤病毒检测技术在不同实验室间的重复性评价研究 [J]. 癌症进展, 2020, 18(05): 456-8 74.

[86]  闫慧姣, 乔友林. HPV疫苗和筛查：人类癌症防治的典范 [J]. 抗癌之窗, 2020, 02): 10-1.

[87]  余艳琴, 郝金奇, 徐慧芳, et al. 宫颈癌综合预防和控制的应用和前景 [J]. 中国医学科学院学报, 2020, 42(04): 535-9.

[88]  余艳琴, 徐慧芳, 郝金奇, et al. 医学人工智能引发的相关伦理问题分析 [J]. 中国医学科学院学报, 2020, 42(01): 128-31.

[89]  张韶凯, 罗喜平, 李志芳, et al. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值 [J]. 中华肿瘤杂志, 2020, 03): 252-3-4-5-6.

[90]  张韶凯, 赵方辉, 乔友林. 中国宫颈癌防治研究20年历程与成就 [J]. 中华流行病学杂志, 2020, 41(06): 809-12.

[91]  张粟, 杨欢, 王国清, et al. 河南省林州市食管鳞癌及癌前病变的影响因素研究 [J]. 中国肿瘤, 2020, 29(05): 327-33.

三、会议论文

 1.             Li Q, Yang Z, Fan J, He J, Zhang B, Yang H, Xie X, Tang Z, Li H, Qiao Y et al. A nation-wide multicenter 10-year (1999-2008) retrospective study of chemotherapy in Chinese breast cancer patients. Journal of Clinical Oncology. 2016, 34(15). doi: 10.1200/JCO.2016.34.15_suppl.e12513.

2.             Wong DT, Wel F, Liao W, Feng Z, Chia D, Kim Y, Qiao Y, Zhou Q. EFIRM liquid biopsy (eLB) to detect actionable mutations in NSCLC. Journal of Clinical Oncology. 2016, 34(15). doi: 10.1200/JCO.2016.34.15_suppl.8520.

3.             Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, Li Y, Kong L, Wei L, Zhang S et al. Cervical cancer screening strategies for evidence-based health care reform in China: a multicentre, open-label randomised trial. Lancet. 2019, 394:20-20. doi:

 ADDIN EN.REFLIST [1]    曾晓敏, 任泽舫, 魏雪灵, et al. 中山大学本科生对HPV及疫苗认知的调查;  2016年广东省药师周大会, 中国广东广州, F, 2015 [C].

[2]    陈凤, 赵宇倩, 连佳, et al. 国产人乳头状瘤病毒(HPV)核酸检测(DH2)与careHPV~(TM)在子宫颈癌癌前病变筛查中可行性与可靠性的比较;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[3]    丁元杰, 魏文强, 李新庆, et al. PLA2G2A基因rs11677多态性与食管鳞癌风险的关联研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[4]    范金虎, 王建炳, Dawsey S M, et al. 饮食成分与总死亡,总癌症死亡,心血管疾病死亡风险之间关系研究——中国林县营养干预试验队列研究结果;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[5]    胡尚英, 冯瑞梅, 赵方辉, et al. 主动、被动吸烟与人乳头瘤病毒感染和宫颈高度癌前病变的关系:一项多中心以人群为基础的横断面研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[6]    姜勇, 范亚光, 常润生, et al. 职业性肺癌危险因素吸入砷与慢性肺部疾病史交互作用的前瞻性队列研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[7]    任建松, Murphy G, 范金虎, et al. 血清B族维生素与食管癌和胃贲门癌发病风险关系的前瞻性研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[8]    孙小伟, 赵方辉, 赵宇倩, et al. 国产HPV核酸检测(DH2)在农村地区宫颈癌筛查中的应用;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[9]    王少明, 范金虎, 杨召, et al. 补充硒、维生素E和β-胡萝卜素对降低人群上消化道癌症死亡率可能有长期持续效益:林县营养干预试验27年随访结果;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[10]  杨召, 王建炳, 王少明, et al. 口腔粘膜白斑可能增加食管癌长期死亡风险:林县营养干预试验28年随访结果;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[11]  张莉, 冯瑞梅, 胡尚英, et al. 宫颈癌筛查轻度异常妇女的患病风险评价;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[12]  张倩, 冯瑞梅, 胡尚英, et al. 山西宫颈癌筛查队列妇女高危HPV感染率的15年变化分析;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[13]  张雨晴, 范金虎, 依荷芭丽·迟, et al. 胃肠胰腺神经内分泌肿瘤全国多中心10年回顾性临床流行病学研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

[14]  赵宇倩, 陈凤, 赵方辉, et al. careHPV在农村基层应用的可行性研究;  全国肿瘤流行病学和肿瘤病因学学术会议, 中国四川成都, F, 2015 [C].

乔友林教授发表的文章完整列表参见：https://orcid.org/0000-0001-6380-0871

Other IDs:

ResearcherID: B-4139-2012

Scopus Author ID: 7202252853

扫描二维码访问乔友林教授的 ORCID ID！